Sangwoo (Steven) Park, Ph.D.

NIH NCI K99/R00 Fellow & Former Damon Runyon Postdoctoral Fellow

@ Harvard Medical School & Massachusetts General Hospital

My research program seeks to define how the biophysical properties of the cell surface shape immune recognition and therapeutic response, and to leverage these principles to engineer more effective cell-based cancer immunotherapies. Specifically, my work focuses on understanding how the cancer glycocalyx regulates immune engagement, developing glycocalyx-targeting and glycocalyx-editing CAR-T cells, and integrating quantitative biophysics with immunoengineering to design next-generation cancer therapies. 

Keywords: Immunoengineering, CAR-T, Glycobiology, Biophysics, Imaging

Email: svvpark [at] gmail.com | spark82 [at] mgh.harvard.edu